Top
FBXO2 has not been detected as a mutational cancer driver

FBXO2
Ensembl id ENSG00000116661
Mutated samples
Coding Sequence 28 (0.4%)
Protein Affecting 10 (0.1%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all FBXO2 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Lung adenocarcinoma No 3 2 0.51
Cutaneous melanoma No 6 2 0.54
Bladder carcinoma No 3 1 1.02
Breast carcinoma No 3 1 0.09
Lung squamous cell carcinoma No 2 1 0.57
Renal clear cell carcinoma No 1 1 0.24
Small cell lung carcinoma No 1 1 1.45
Esophageal carcinoma No 2 1 0.68
Thyroid carcinoma No 1 0 0.00
Serous ovarian adenocarcinoma No 1 0 0.00
Stomach adenocarcinoma No 1 0 0.00
Head and neck squamous cell carcinoma No 3 0 0.00
Glioblastoma multiforme No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence